Found 7 matching trials
A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers
PHASE1This study will be conducted in a single centre, as an open single dose two...
Location
Richmond Pharmacology Ltd.
Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A
PHASE1This Phase I study will evaluate the safety, tolerability and pharmacokinet...
Phase I Study of Ascending Doses of MMV390048 in Healthy Adult Volunteers
PHASE1This is a first-in-human study of MMV390048. The study will evaluate the sa...
Location
Cinical Pharmacology, University of Cape Town
MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B
PHASE1Pharmacodynamic profiling will also be studied to characterize the effects ...
MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants
PHASE1A single-centre, open-label, study using induced blood stage malaria infect...
Location
Q-Pharm Clinics, Royal Brisbane and Women's Hospital
MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria
PHASE2The present proof-of-concept Phase IIa study aims to confirm, in patients, ...
Location
University of Gondar Hospital/Maksegnit Health Centre
Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model
PHASE1This study follows a First-In-Human dose-escalation study of MMV390048 (5 t...
Location
Institute of Tropical Medicine / Centre for Clinical Trials, Eberhard Karls University